first glp 1 approval World Pharma Today | ๐ The FDA has approved the GLP-1 pill for obesity developed by Novo Nordisk, expected to be available by 2026. This treatment, with a New GLP-1 Pill Foundayo (Orforglipron)
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 5 - Aug 10




























